o NoneEntity Type
0001817944
Blue Water Acquisition Corp.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Clarus Therapeutics Holdings, Inc.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  o Over Five Years Ago
  x Within Last Five Years (Specify Year) 2020
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Clarus Therapeutics Holdings, Inc. 
Street Address 1Street Address 2
 555 SKOKIE BOULEVARD, SUITE 340 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 NORTHBROOK ILLINOIS 60062 (847) 562-4300 



3. Related Persons
Last NameFirst NameMiddle Name
DudleyRobertE.
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
PetersonRichard
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
PrygockiMarkA.
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
CermakElizabeth
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
BourneStevenA.
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ZissonAlex
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
AmoryJohnKenneth
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
HernandezJoseph
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
MurphyKimberly
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
JaegerFrank
Street Address 1Street Address 2
c/o Clarus Therapeutics Holdings, Inc.555 SKOKIE BOULEVARD, SUITE 340
CityState/Province/CountryZIP/Postal Code
NORTHBROOKILLINOIS60062
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2021-12-07 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 15000002 USD o Indefinite
Total Amount Sold $ 15000002 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 Private placement of shares of common stock, warrants to purchase shares of common stock at an exercise price of $5.25 and pre-funded warrants at an exercise price of $0.00001


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 900000 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Blue Water Acquisition (NASDAQ:BLUWU)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024 Haga Click aquí para más Gráficas Blue Water Acquisition.
Blue Water Acquisition (NASDAQ:BLUWU)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024 Haga Click aquí para más Gráficas Blue Water Acquisition.

Noticias sobre Clarus Therapeutics Holdings, Inc. BLUWU

Real-Time news about Blue Water Acquisition Corporation (NASDAQ): 0 recent articles

Más de Clarus Therapeutics Holdings, Inc. Artículos de Noticias